Halo Labs Launches Larger Volume Membrane Plate for Process Developers and Manufacturers
BURLINGAME, CA – Halo Labs, a leading developer of particle analysis instrumentation for biotherapeutics, announced the launch of large volume white membrane plates specifically designed for process developers and biotherapeutic manufacturers. These plates enable 10x more sample volume analysis.
Aura® systems utilize proprietary membrane plates for Background Membrane Imaging (BMI), Fluorescence Membrane Microscopy (FMM), and Side Illumination Membrane Imaging (SIMI) for industry-leading particle and drug product characterization requiring just 5 µL of sample perfect for volume-limited applications like early phase development and gene therapy. But with large volume membrane plates, late phase development users and drug manufacturers can now characterize therapeutics with at least 400 µL.
“Our biologics users further down in development and cell therapy have often asked for larger volume BMI solutions for particle characterization,” said Rick Gordon, CEO of Halo Labs. “Our new large volume membrane plates meet this need and open up a wider variety of applications downstream where sample volume is not typically limited.”
The initial offering of large volume membrane plates will be configured for white membranes with 0.8 µm pores to be used with Aura systems only.
About Halo Labs
Halo Labs in Burlingame, CA is a venture-backed scientific instrumentation and consumable company that commercializes high throughput biopharmaceutical formulation, stability, and product quality control tools for aggregate and subvisible particle analysis using state-of-the-art custom optics and image processing techniques. Biopharmaceutical companies around the globe depend on Halo Labs for unprecedented insights into their drug products. For more information, visit halolabs.com.
